Larkspur Health LLC - Dec 20, 2021 Form 3 Insider Report for Larkspur Health Acquisition Corp. (ZVSA)

Role: 10%+ Owner
Signature: /s/ Daniel O'Connor, Managing Member
Stock symbol: ZVSA
Transactions as of: Dec 20, 2021
Transactions value $: $0
Form type: 3
Date filed: 3/10/2022, 04:29 PM
Next filing: Mar 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ZVSA	Class A Common Stock						236K	Dec 20, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ZVSA	Class B Common Stock							Dec 20, 2021	Class A Common Stock	1.14M		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are underlying private placement units acquired by the Reporting Person in a private placement that closed simultaneously with the issuer's initial public offering and subsequent partial over-allotment exercise. Each private placement unit consists of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock.
F2	As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date.
F3	The Reporting Person initially acquired 1,263,575 shares of Class B Common Stock. On March 8, 2022, the Reporting Person forfeited 125,676 shares of Class B Common Stock because the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the Registration Statement.